FIFRA Scientific Advisory Panel Considers Nanosilver
Date | 01 December 2009 |
Author |
12-2009 NEWS & ANALYSIS 39 ELR 11143
C O L U MN S
FIFRA Scientific Advisory
Panel Considers Nanosilver
by Lynn L. Bergeson
Lynn L. Bergeson is Managing Director of Bergeson & Campbell, P.C., a
Washington, D.C., law rm focusing on conventional and engineered nanoscale
chemical, pesticide, and other specialty chemical product approval and regulation,
environmental health and safety law, chemical product litigation, and associated
business issues. She is also President of e Acta Group, L.L.C., and e Acta
Group EU, Ltd, with oces in Washington, D.C., and Manchester, UK.
On November 3-5, 2009, the
Federal Insecticide, Fungicide,
and Rodenticide Act (FIFRA)
Scientic Advisory Panel (SAP) met
“to consider and review a set of scien-
tic issues related to the assessment of
hazard a nd exposure associated with
nanosilver and other nanometal pes-
ticide products.” e decision to con-
vene an SAP was nomina lly motivated
by the U.S. Environmental Protection
Agency’s (EPA’s) need to consider four
applications pending at the Oce
of Pesticide Programs (OPP) seeking
registration of productscontaining
nanosilver-based active ingredients.
e nanosilver products, which
would take the form of textile addi-
tives, polymers, coatings, and/or
plastics, would be used to protect a
treated product from microorganisms
or to impart antimicrobial activity to
a treated materia l. Accordingly, they
would be used in the same manner as
some of the currently registered sil-
ver products, includingthose used as
materials preservative s and antimicro-
bial pesticides. Notably, many of the
110 currently registered silver-based
products actually contain nanosilver.1
1. As noted in the SAP Background Paper, EPA “has
information suggesting that there are other pes-
ticide products currently in the marketplace that
contain nanosilver.” e Silver Nanotechnology
Working Group (SNWG), an industry group
formed to promote the benecial uses of silver
nanoparticles that testied before and submit-
ted comment to the SAP, went so far as to claim
that “all EPA registered silver products through
to 1994 were nanoscale” (emphasis added) and
“the majority of existing registered silver products
Unmentioned in either the Septem-
ber 16, 2009, Federal Registernotice
announcing the public meeting or the
SAP Background Document EPA pre-
pared in connection with the meeting
is a May 2008 petition submitted by
the International Center for Technol-
ogy Assessment (ICTA) and others
requesting, among other actions, that
EPA classify nanosilver as a pesticide,
require the registration under FIFRA
of nanosilver products, and determine
that nanosilver is a new pesticide that
requires a new FIFRA pesticide registra-
tion (available at http://www.icta.org/
nanoaction/doc/CTA_nano-silver%20
petition_nal_5_1_08.pdf).
Core Issue
EPA states in its Background Paper that
“the current state of the science does not
contain sucient information to deter-
mine denitively whether (and, if so, to
what extent) various forms of nanosilver
particles may cause toxic eects beyond
those attributable to the release of silver
ions.” In light of this, the threshold ques-
tion before the SAP relates to whether
EPA can make its safety nding under
FIFRA that a pesticide product will not
cause “unreasonable adverse eects on
the environment” with respect to the
four pending applications.
According to EPA, the registration
applicants claim that “the mode of
action for nanosilveris the same as for
are nanosilver, including the algaecides and water
lters that have been used for decades.”
silver in that the release of silver ions
is the source of antimicrobial activ-
ity.” Because the pesticidal mode of
action of nanosilver is the same as for
conventionally sized silver, the poten-
tial hazards to human health and the
environment resulting from the use of
nanosilver as a pesticide will therefore
be the same as from the use of silver.
EPA likened the registrants’ argument
to that of the so-called 0-hypothesis put
forward by S. Wijnhoven et al.(2009).
e 0-hypothesis states that the toxic
eects of nanosilver are proportional to
the activity of free silver ions released by
the nanoparticles. e question, then,
for FIFRA regulatory purposes becomes
whether sucient data and information
exist to validate the hypothesis. is
requires a two-step process: (1) deter-
mine whether nanosilver particles enter
the body; and (2) determine whether
nanosilver releases silver ions and to
what extent the ions will be absorbed.
EPA further states that registration
applicants posit that there will be no
or only trivial levels of human expo-
sure to nanosilver particles since these
particles will not leach from nished
products. As a result, any toxic eect to
humans would be the result of exposure
Lynn L. Bergeson
Copyright © 2009 Environmental Law Institute®, Washington, DC. reprinted with permission from ELR®, http://www.eli.org, 1-800-433-5120.
To continue reading
Request your trialUnlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology

Unlock full access with a free 7-day trial
Transform your legal research with vLex
-
Complete case access with no limitations or restrictions
-
AI-generated case summaries that instantly highlight key legal issues
-
Comprehensive legal database spanning 100+ countries and all 50 states
-
Advanced search capabilities with precise filtering and sorting options
-
Verified citations and treatment with CERT citator technology
